ONCOPEP
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. The technology, which OncoPep has exclusively licensed from Dana Farber, employs a unique combination of proprietary peptides to form a therapeutic cancer vaccine. Vaccines developed from this technology are designed to stimulate the patient’s immune system to attack his or her cancer through an optimized combination of disease-specific peptides and adjuvants (substances that stimulate the immune system).
ONCOPEP
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
North Andover, Massachusetts, United States
Country:
United States
Website Url:
http://www.oncopep.com
Total Employee:
1+
Status:
Active
Contact:
+1 978 837 1129
Email Addresses:
[email protected]
Total Funding:
28.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Investors List
Crystal Bioscience
Crystal Bioscience investment in Series D - OncoPep
Kukje Pharma
Kukje Pharma investment in Series D - OncoPep
Tera Science
Tera Science investment in Series D - OncoPep
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Series B - OncoPep
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-17 | Dr. Victor Moyo, MBChB, Joins OncoPep as Chief Medical Officer |
Official Site Inspections
http://www.oncopep.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.44 K
- Host name: 72.65.245.35.bc.googleusercontent.com
- IP address: 35.245.65.72
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "OncoPep"
Our Company - OncoPep, Inc.
Our core multi-peptide vaccine was developed in the labs of world-renowned oncology researchers at the Dana-Farber Cancer Institute. In 2009, Kenneth Anderson, M.D., Joouen …See details»
OncoPep - Crunchbase Company Profile & Funding
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The company's proprietary core technology was …See details»
Overview - About Us - OncoPep
Overview. OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was …See details»
OncoPep Company Profile | Management and Employees List
OncoPep Profile and History OncoPep, Inc., located in North Andover, Massachusetts, is a biotech company that specializes in developing targeted immunotherapeutics against cancer. …See details»
OncoPep Company Profile 2024: Valuation, Funding & Investors
OncoPep General Information Description. Developer of a therapeutic cancer vaccine designed for immuno-therapeutics against cancer. The company's vaccines are designed to stop …See details»
OncoPep, Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OncoPep, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Board of Directors - About Us - OncoPep
The OncoPep Board of Directors is comprised of advisors with significant experience in the life science industry, including drug and immunotherapeutic development in the oncology field, as …See details»
Contact - OncoPep, Inc.
OncoPep, Inc. 222 3rd Street Suite 1100 Cambridge, MA 02142 +1-774-227-3818. OncoPep Korea #13-022, 13F (Seoul Square, Namdaemun-ro 5-Ga) 416 Hangang-daero, Jung-GuSee details»
OncoPep
OncoPep's lead program is a therapeutic cancer vaccine for use in treating smoldering multiple myeloma. Learn More. news. OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX …See details»
OncoPep - Org Chart, Teams, Culture & Jobs - The Org
View OncoPep's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
OncoPep - Contacts, Employees, Board Members, Advisors & Alumni
Organization. OncoPep . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. OncoPep has 4 current employee profiles, …See details»
OncoPep - Overview, News & Similar companies | ZoomInfo.com
OncoPep, Inc., located in North Andover, Massachusetts, is a biotech company that specializes in developing targeted immunotherapeutics against can cer. The technology, which OncoPep …See details»
OncoPep - Company Profile - Tracxn
Oct 4, 2024 OncoPep’s lead program, PVX-410, is a multi-peptide therapeutic cancer vaccine that is designed to target specific antigens found on the surface of multiple myeloma (MM) …See details»
Michael D. Krepps - COO at OncoPep - The Org
Mike leads all strategic and operational efforts for OncoPep. He also serves as an EIR with Cobro Ventures. Prior to joiningOncoPep as COO, Mike worked as a scientist, consultant, …See details»
OncoPep Company Profile - Office Locations, Competitors ... - Craft
OncoPep has 1 employees at their 1 location and $6.9 m in total funding,. See insights on OncoPep including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
OncoPep - Updates, News, Events, Signals & Triggers - Crunchbase
OncoPep may be growing as it is mentioned alongside other companies in the context of the triple-negative breast cancer market, which is predicted to grow rapidly during the forecast …See details»
Our Science - OncoPep, Inc.
Here’s the basic science behind OncoPep’s Adoptive T cell therapy … OncoPep licensed an autologous multi-tumor antigen adoptive T cell (MTAA) approach from MANA Therapeutics in …See details»
OncoPep to Present Clinical and Pipeline Update to Investors at …
Jan 9, 2023 OncoPep, Inc. is developing novel immunotherapeutics to prevent the progression of cancer, extend survival, and restore the quality of life of patients. OncoPep’s lead program, …See details»
OncoPep Completes $11 Million Series D Financing to Continue …
Cambridge, MA – December 09, 2021 – OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by …See details»